JP2001512488A5 - - Google Patents

Download PDF

Info

Publication number
JP2001512488A5
JP2001512488A5 JP1998536878A JP53687898A JP2001512488A5 JP 2001512488 A5 JP2001512488 A5 JP 2001512488A5 JP 1998536878 A JP1998536878 A JP 1998536878A JP 53687898 A JP53687898 A JP 53687898A JP 2001512488 A5 JP2001512488 A5 JP 2001512488A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998536878A
Other languages
English (en)
Other versions
JP2001512488A (ja
JP4563516B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/003256 external-priority patent/WO1998036738A1/en
Publication of JP2001512488A publication Critical patent/JP2001512488A/ja
Publication of JP2001512488A5 publication Critical patent/JP2001512488A5/ja
Application granted granted Critical
Publication of JP4563516B2 publication Critical patent/JP4563516B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

Figure 2001512488
Figure 2001512488
Figure 2001512488
Figure 2001512488
Figure 2001512488
JP53687898A 1997-02-20 1998-02-20 迅速分散性を示す投与剤形、その使用法並びにその製造方法 Expired - Lifetime JP4563516B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3888397P 1997-02-20 1997-02-20
US3828497P 1997-02-20 1997-02-20
US60/038,284 1997-02-20
US60/038,883 1997-02-20
PCT/US1998/003256 WO1998036738A1 (en) 1997-02-20 1998-02-20 Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2009114753A Division JP5091910B2 (ja) 1997-02-20 2009-05-11 迅速分散性を示す投与剤形、その使用法並びにその製造方法
JP2009256374A Division JP2010120938A (ja) 1997-02-20 2009-11-09 迅速分散性を示す投与剤形医薬組成物

Publications (3)

Publication Number Publication Date
JP2001512488A JP2001512488A (ja) 2001-08-21
JP2001512488A5 true JP2001512488A5 (ja) 2005-10-06
JP4563516B2 JP4563516B2 (ja) 2010-10-13

Family

ID=26715043

Family Applications (3)

Application Number Title Priority Date Filing Date
JP53687898A Expired - Lifetime JP4563516B2 (ja) 1997-02-20 1998-02-20 迅速分散性を示す投与剤形、その使用法並びにその製造方法
JP2009114753A Expired - Lifetime JP5091910B2 (ja) 1997-02-20 2009-05-11 迅速分散性を示す投与剤形、その使用法並びにその製造方法
JP2009256374A Withdrawn JP2010120938A (ja) 1997-02-20 2009-11-09 迅速分散性を示す投与剤形医薬組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009114753A Expired - Lifetime JP5091910B2 (ja) 1997-02-20 2009-05-11 迅速分散性を示す投与剤形、その使用法並びにその製造方法
JP2009256374A Withdrawn JP2010120938A (ja) 1997-02-20 2009-11-09 迅速分散性を示す投与剤形医薬組成物

Country Status (9)

Country Link
US (3) US6471992B1 (ja)
EP (1) EP0973507B1 (ja)
JP (3) JP4563516B2 (ja)
AT (1) ATE421318T1 (ja)
AU (1) AU736912B2 (ja)
CA (1) CA2281473C (ja)
DE (1) DE69840495D1 (ja)
ES (1) ES2318869T3 (ja)
WO (1) WO1998036738A1 (ja)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6471992B1 (en) 1997-02-20 2002-10-29 Therics, Inc. Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
CN1195500C (zh) * 1998-05-18 2005-04-06 武田药品工业株式会社 可口腔崩解的片剂
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
EP1301177A2 (en) * 2000-07-10 2003-04-16 Therics, Inc. Method and materials for controlling migration of binder liquid in a powder
US7014867B2 (en) * 2001-06-28 2006-03-21 Ucb Farchim Sa Tablet comprising cetirizine and pseudoephedrine
KR100892333B1 (ko) * 2001-07-10 2009-04-08 테바 파마슈티컬 인더스트리즈 리미티드 0차, 0차-2상, 증가적 또는 감소적 약물 전달을 위한 약물전달 시스템
JP4845340B2 (ja) * 2001-10-29 2011-12-28 マサチューセッツ インスティテュート オブ テクノロジー 三次元プリント投薬形態のような物品の一軸圧縮のためのシステムおよび方法
US20030099708A1 (en) * 2001-10-29 2003-05-29 Therics, Inc Printing or dispensing a suspension such as three-dimensional printing of dosage forms
AU2003232078A1 (en) 2002-05-06 2003-11-17 Massachusetts Institute Of Technology Diffusion-controlled dosage form and method of fabrication including three dimensional printing
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
DK1804804T3 (da) 2004-09-21 2012-02-20 Hypnion Inc 3-[4-(dibenzo[b,f][1,4]oxazepin-11-yl)-piperazin-1-yl]-2,2-dimethylpropansyre til anvendelse ved behandlingen af søvnforstyrrelser
US7829000B2 (en) * 2005-02-25 2010-11-09 Hewlett-Packard Development Company, L.P. Core-shell solid freeform fabrication
US8187659B2 (en) 2006-05-02 2012-05-29 Jerry Robertson Real Estate Llc Solid medicament dosage form consumption aid
ES2500165T3 (es) 2006-06-29 2014-09-30 Kinex Pharmaceuticals, Llc Composiciones de biarilo y métodos para modular una cascada de quinasas
WO2009051848A1 (en) 2007-10-20 2009-04-23 Kinex Pharmaceuticals, Llc Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
MY150626A (en) 2009-10-30 2014-02-07 Ix Biopharma Ltd Fast dissolving solid dosage form
ES2634551T3 (es) * 2010-04-03 2017-09-28 Praful Doshi Métodos para revestir una lente de contacto
EP2632920A1 (en) 2010-10-27 2013-09-04 Dynamix Pharmaceuticals Ltd. Sulfonamides for the modulation of pkm2
WO2012088438A1 (en) 2010-12-22 2012-06-28 Eutropics Pharmaceuticals, Inc. Compositions and methods useful for treating diseases
WO2012106058A2 (en) 2011-01-31 2012-08-09 New Market Pharmaceuticals Animal treatments
WO2012122370A2 (en) 2011-03-08 2012-09-13 Eutropics Pharmaceuticals, Inc. Compositions and methods useful for treating diseases
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
WO2012160447A1 (en) 2011-05-25 2012-11-29 Dynamix Pharmaceuticals Ltd. 3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
PL2718290T3 (pl) 2011-06-07 2016-11-30 Kompozycje i sposoby modulowania kinazy
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
US9245061B2 (en) * 2012-04-25 2016-01-26 Shapeways, Inc. Weight-based identification of three dimensional printed parts
BR112014027352B1 (pt) 2012-05-02 2022-10-25 New Market Pharmaceuticals Composições farmacêuticas para a introdução sistêmica direta
US20150150869A1 (en) 2012-06-20 2015-06-04 Eutropics Pharmaceuticals, Inc. Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
SI2890680T1 (en) 2012-08-30 2018-08-31 Athenex, Inc. Conventus Building N- (3-FLUOROBENZYL) -2- (5- (4-MORFOLINOPHENYL) PIRIDIN-2-IL) ACETAMIDE AS PROTEIN TIROZINE KINASE PROTECTORS
US9545376B2 (en) 2013-01-23 2017-01-17 Arx, Llc Production of unit dose constructs
CA2906107C (en) * 2013-03-15 2021-08-24 Aprecia Pharmaceuticals Company Rapidly dispersible dosage form of oxcarbazepine
CN105050588B (zh) * 2013-03-15 2019-01-15 阿普雷奇亚制药有限责任公司 托吡酯的快速分散剂型
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
CN105188849B (zh) * 2013-03-15 2019-01-15 阿普雷奇亚制药有限责任公司 包含左乙拉西坦的快速分散剂型
WO2014176389A1 (en) 2013-04-24 2014-10-30 Temple University - Of The Commonwealth System Of Higher Education Solid dosage form containing arabinogalactan
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
KR102171123B1 (ko) 2013-08-16 2020-10-29 더 엑스원 컴퍼니 3차원 인쇄된 금속 주조용 몰드 및 그를 제조하기 위한 방법
JP2016540887A (ja) 2013-10-17 2016-12-28 ザ エクスワン カンパニー 3次元印刷された熱間静水圧加圧成形用容器及びその製造方法
EP3086922B1 (en) 2013-12-23 2022-03-09 The Exone Company Method of three-dimensional printing using a multi-component build powder
ES2744846T3 (es) * 2013-12-23 2020-02-26 The Exone Co Métodos y sistemas para la impresión en tres dimensiones, utilizando un fluido aglutinante de partículas inyectadas
US20160332373A1 (en) 2013-12-23 2016-11-17 The Exone Company Methods and Systems for Three-Dimensional Printing Utilizing Multiple Binder Fluids
US20160184230A1 (en) * 2014-04-30 2016-06-30 Aron H. Blaesi Melt-processed polymeric cellular dosage form
WO2015183796A1 (en) 2014-05-29 2015-12-03 The Exone Company Process for making nickel-based superalloy articles by three-dimensional printing
WO2016011098A2 (en) 2014-07-17 2016-01-21 The Exone Company Methods and apparatuses for curing three-dimensional printed articles
KR102580378B1 (ko) 2014-11-21 2023-09-19 바이오하벤 파마슈티컬 홀딩 컴퍼니 엘티디. 릴루졸의 설하 제제
CN107206746A (zh) 2014-12-03 2017-09-26 艾克斯温有限责任公司 通过三维打印制造致密碳制品的方法
US10363220B2 (en) 2015-06-03 2019-07-30 Triastek, Inc. Compartmented pharmaceutical dosage forms
EP3108874A1 (en) * 2015-06-26 2016-12-28 TRB Chemedica AG Ophthalmologic pharmaceutical composition
US11129798B2 (en) * 2016-08-19 2021-09-28 Aron H. Blaesi Fibrous dosage form
WO2017158172A1 (en) * 2016-03-18 2017-09-21 Grünenthal GmbH Combination of drugs having different potency
WO2017175792A1 (ja) * 2016-04-06 2017-10-12 アステラス製薬株式会社 速溶出性三次元造形物、速溶出性三次元造形物用フィラメント及び速溶出性三次元造形物用材料
JP6559912B2 (ja) 2016-05-05 2019-08-14 トリアステック インコーポレイテッド 放出制御剤形
ES2912131T3 (es) 2016-05-20 2022-05-24 Biohaven Therapeutics Ltd Uso de agentes moduladores del glutamato con inmunoterapias para tratar el cáncer
CA3032586A1 (en) 2016-08-12 2018-02-15 Athenex, Inc. Biaryl compounds and use thereof for modulating a kinase cascade
EP3529023B1 (en) 2016-10-19 2022-05-25 Shapeways, Inc. Systems and methods for identifying three-dimensional printed objects
MX2019007923A (es) 2016-12-31 2019-09-10 Bioxcel Therapeutics Inc Uso de dexmedetomidina sublingual para el tratamiento de la agitacion.
US11602502B2 (en) 2017-02-24 2023-03-14 Hewlett-Packard Development Company, L.P. Three-dimensional (3D) printing a pharmaceutical tablet
CA3053254C (en) 2017-03-08 2024-02-20 Cinrx Pharma, Llc Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
KR102626745B1 (ko) 2017-05-26 2024-01-17 인피니트 머티리얼 솔루션즈, 엘엘씨 수용성 중합체 조성물
WO2019094851A1 (en) 2017-11-12 2019-05-16 Biohaven Pharmaceutical Holding Company Ltd. Use of riluzole prodrugs to treat ataxias
CN108066302B (zh) * 2017-12-28 2020-09-11 无限极(中国)有限公司 一种快速分散固体制剂的制备方法及制备的快速分散固体制剂
US10350822B1 (en) 2018-01-09 2019-07-16 Triastek Inc. Dosage forms with desired release profiles and methods of designing and making thereof
CN116270513A (zh) 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
DE102018107585B3 (de) * 2018-03-29 2019-03-28 Universität Rostock Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen
US10792246B2 (en) 2018-06-27 2020-10-06 Bioxcel Therapeutics, Inc. Film formulations containing dexmedetomidine and methods of producing them
SG11202103708RA (en) 2018-10-15 2021-05-28 Aprecia Pharmaceuticals LLC Method and system for forming a dosage form within a packaging
US20220016074A1 (en) 2018-11-21 2022-01-20 Rosemont Pharmaceuticals Limited Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
JP7287032B2 (ja) 2019-03-20 2023-06-06 株式会社リコー シート、シート積層体、医薬品、シートの製造方法、及びシート積層体の製造方法
WO2020234335A1 (en) * 2019-05-21 2020-11-26 Dfe Pharma Gmbh & Co. Kg Lactose powder bed three dimensional printing
US20240024288A1 (en) 2019-07-19 2024-01-25 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
TWI734309B (zh) * 2019-12-19 2021-07-21 水星生醫股份有限公司 滲透性噴塗製作藥錠裝置
WO2021263132A1 (en) 2020-06-26 2021-12-30 Aprecia Pharmaceuticals LLC Rapidly-orodispersible tablets having an interior cavity
WO2022089588A1 (zh) 2020-10-30 2022-05-05 南京三迭纪医药科技有限公司 胃滞留药物剂型
WO2024108082A1 (en) 2022-11-18 2024-05-23 Aprecia Pharmaceuticals LLC Orodispersive dosage forms containing droxidopa

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4642903A (en) 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
US4855326A (en) 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
FR2647343B1 (fr) * 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5204055A (en) 1989-12-08 1993-04-20 Massachusetts Institute Of Technology Three-dimensional printing techniques
US5578322A (en) 1990-11-30 1996-11-26 Yamanouchi Pharmaceutical Co., Ltd. Quick release coated preparation
ATE131111T1 (de) 1991-01-31 1995-12-15 Texas Instruments Inc Verfahren und vorrichtung zur rechnergesteuerten herstellung von dreidimensionalen gegenständen aus rechnerdaten.
ES2087558T3 (es) * 1991-12-20 1996-07-16 Pfizer Medios de administracion conformados porosos, y procedimiento de produccion de los mismos.
JP2521612B2 (ja) * 1992-05-20 1996-08-07 ウエイ・ミン・フアーマシユーテイカル・マニユフアクチヤリング・カンパニー・リミテツド 直接錠剤形成助剤
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5380473A (en) 1992-10-23 1995-01-10 Fuisz Technologies Ltd. Process for making shearform matrix
DE4303846A1 (de) * 1993-02-10 1994-08-11 Merck Patent Gmbh Verfahren zur Herstellung einer S-Ibuprofen enthaltenden Tablette
US5631023A (en) 1993-07-09 1997-05-20 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
US6280771B1 (en) 1997-02-20 2001-08-28 Therics, Inc. Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof
US5490962A (en) 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US6176874B1 (en) 1993-10-18 2001-01-23 Masschusetts Institute Of Technology Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
US5503785A (en) 1994-06-02 1996-04-02 Stratasys, Inc. Process of support removal for fused deposition modeling
US5633021A (en) 1994-10-19 1997-05-27 Bpm Technology, Inc. Apparatus for making a three-dimensional article
US5607697A (en) 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
US5560927A (en) * 1995-07-28 1996-10-01 Isp Investments Inc. Co-processing method for making a free-flowing compressible powder and tablet therefrom
US5653925A (en) * 1995-09-26 1997-08-05 Stratasys, Inc. Method for controlled porosity three-dimensional modeling
US6471992B1 (en) 1997-02-20 2002-10-29 Therics, Inc. Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
DE19940944B4 (de) * 1999-08-31 2006-10-12 Grünenthal GmbH Retardierte, orale, pharmazeutische Darreichungsformen

Similar Documents

Publication Publication Date Title
JP2000510751A5 (ja)
JP2000509942A5 (ja)
JP2000509912A5 (ja)
JP2000507042A5 (ja)
JP2000509637A5 (ja)
JP2000509635A5 (ja)
JP2001512488A5 (ja)
JP2000507433A5 (ja)
JP2000509587A5 (ja)
JP2000507369A5 (ja)
JP2001526670A5 (ja)
JP2001527558A5 (ja)
JP2000510793A5 (ja)
JP2000508022A5 (ja)
JP2000508680A5 (ja)
JP2000509804A5 (ja)
JP2000509853A5 (ja)
JP2000510969A5 (ja)
JP2000509755A5 (ja)
JP2002515124A5 (ja)
JP2000509818A5 (ja)
JP2000509520A5 (ja)
JP2000510247A5 (ja)
JP2000507434A5 (ja)
JP2000508880A5 (ja)